These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 29427746)

  • 1. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery systems using polymer nanoassemblies for cancer treatment.
    Bae Y
    Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
    [No Abstract]   [Full Text] [Related]  

  • 5. Size matters: gold nanoparticles in targeted cancer drug delivery.
    Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
    Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G; Hatakeyama H; Harashima H
    Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
    Elbayoumi TA
    Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracellular stability of nanoparticulate drug carriers.
    Liu KC; Yeo Y
    Arch Pharm Res; 2014 Jan; 37(1):16-23. PubMed ID: 24214175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
    Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
    Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.
    Lee MS; Dees EC; Wang AZ
    Oncology (Williston Park); 2017 Mar; 31(3):198-208. PubMed ID: 28299757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
    Mohamed S; Parayath NN; Taurin S; Greish K
    Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer nanomedicine: from targeted delivery to combination therapy.
    Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O
    Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications.
    Jeong EH; Jung G; Hong CA; Lee H
    Arch Pharm Res; 2014 Jan; 37(1):53-9. PubMed ID: 24214174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising effects of nanomedicine in cancer drug delivery.
    Wakaskar RR
    J Drug Target; 2018 Apr; 26(4):319-324. PubMed ID: 28875739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-Based Nanodevices as Drug Carriers.
    Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
    Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.